Related Experiment Video

Updated: May 2, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

555

The role of microRNAs in melanoma

Chonglin Luo1, Claudia E M Weber1, Wolfram Osen1

  • 1Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

European Journal of Cell Biology
|March 8, 2014
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in melanoma development and progression. This review covers miRNA identification, functions in melanoma, and their potential as prognostic markers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melanoma is an aggressive skin cancer, often resistant to standard treatments.
  • Understanding melanoma's molecular underpinnings is crucial for new therapies.
  • MicroRNAs (miRNAs) regulate gene expression and are implicated in various cancers, including melanoma.

Purpose of the Study:

  • To review methods for identifying candidate miRNAs and their gene targets in melanoma.
  • To summarize the known functions of miRNAs in melanoma initiation and progression.
  • To highlight recent advances in using miRNAs as prognostic markers and therapeutic targets.

Main Methods:

  • Literature review of studies on miRNA identification and function in melanoma.
  • Analysis of miRNA roles in cellular signaling pathways relevant to melanoma.
  • Summary of pre-clinical research on miRNA-based biomarkers and therapies.

Main Results:

  • miRNAs significantly influence melanoma development and metastasis.
  • Various miRNAs have been identified as potential regulators of melanoma.
  • Pre-clinical studies show promise for miRNAs in melanoma prognosis and treatment.

Conclusions:

  • miRNAs represent a critical area for understanding melanoma.
  • Further research into miRNA functions could lead to novel therapeutic strategies.
  • miRNAs show potential as biomarkers and targets for melanoma treatment.
Keywords:
BioinformaticsDiagnosisExpression profilingMelanomaMicroRNAOncogeneTarget identificationTherapyTumor markerTumor suppressor

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K